In its accelerated approval decisions of new cancer drugs, the FDA might be underestimating the willingness of some patients ...
Donald Trump’s election as US president and his threats to impose sweeping tariffs on imports has given the EU fresh impetus to seal new trade deals. But at the G20 summit in Rio de Janeiro — ...